Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-001982-41Phase 4Completed
Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Bradford Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in NT-proBNP concentration from baseline. Started Sep 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-001982-41.